Risk of perinatal mortality associated with inhaled corticosteroid use for the treatment of asthma during pregnancy

The risk of perinatal mortality was not found to be significantly associated with ICS use during pregnancy. The result associated with higher doses of ICSs is limited due to a lack of statistical power and a possibility of residual confounding by asthma severity and control.